Codex Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.27 M
as on 16-11-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 16-11-2024
- Revenue 109.73%
(FY 2023)
- Profit -11.72%
(FY 2023)
- Ebitda 250.11%
(FY 2023)
- Net Worth 19.56%
(FY 2023)
- Total Assets 14.83%
(FY 2023)
About Codex Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.27 M.
The company currently has active open charges totaling ₹3.00 M.
Vinay Chutke, Rohan Panse, and Isha Kedia serve as directors at the Company.
- CIN/LLPIN
U85300PN2017PTC172052
- Company No.
172052
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Codex Healthcare Private Limited offer?
Codex Healthcare Private Limited offers a wide range of products and services, including Hotel Booking & Reservation Services, Hospitality Services.
Who are the key members and board of directors at Codex Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Chutke  | Managing Director | 16-Aug-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohan Panse | Director | 16-Aug-2017 | Current |
| Isha Kedia | Director | 22-Apr-2023 | Current |
Financial Performance of Codex Healthcare.
Codex Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 109.73% increase. The company also saw a substantial fall in profitability, with a 11.72% decrease in profit. The company's net worth Soared by an impressive increase of 19.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Codex Healthcare?
In 2023, Codex Healthcare had a promoter holding of 63.73% and a public holding of 36.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 May 2023 | ₹3.00 M | Open |
How Many Employees Work at Codex Healthcare?
Unlock and access historical data on people associated with Codex Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Codex Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Codex Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
